DrMerpMcMerpleton Posted - 1 hour ago

$APLS almost time to acquire some long dated calls here

Paul_Volcker Posted - 10 hours ago

$APLS Let's see if there's a big MOC order

Paul_Volcker Posted - 10 hours ago

$APLS Is something happening here?

BirdStar Posted - 10 hours ago

$APLS Impressive move.

Paul_Volcker Posted - 10 hours ago

$APLS Great price action by only 73% normal volume

hope_my_calls_print Posted - 10 hours ago

$APLS those last two candles

hope_my_calls_print Posted - 12 hours ago

$APLS

APman Posted - 12 hours ago

$APLS Shorts will have to cover eventually.

Sporked Posted - 13 hours ago

$APLS resistance around this area. Nice movement today. Needs to clear 30.50ish for a breakout. Bottom might be in. 1 hr chart

Paul_Volcker Posted - 13 hours ago

$APLS

scott52 Posted - 14 hours ago

$APLS Yeah. This stock action is completely normal:-) Hey, SEC, there's nothing to see here. Go back to sleep.

ribbey Posted - 14 hours ago

@jenbunn @cubie @simon58 @judgeyoung2 @Alvi722 @Ollip @EBE_Day @TraderRapp @tonyctl @lukenight $APLS I marked these $0.01 calls couple days ago for fun. They’re $1.15 now for +11,400%. No biggie 😳

crazysnake Posted - 14 hours ago

$OCGN this stock is going to be the leader in ophtalmology too bad if you cant see it its going to destroy $APLS $BLTE $RHHBY (spark) the superior treatment always win

buylowandwait Posted - 15 hours ago

$APLS The CRL from FDA on Izervay is life changing event for this company. Perfect time to regain its old glory as GA is huge market.

stockfoxthejoker Posted - 15 hours ago

$APLS Future Prospects for IZERVAY: Even if Astellas resubmits the 24-month data, the likelihood of the FDA endorsing treatment beyond 24 months is slim. If the label remains limited to 12 months (or even extends to 24 months), IZERVAY's market position will likely remain impaired. Syfovre’s Competitive Advantage: With a more robust and flexible label, Syfovre is well-positioned to retain the majority market share over IZERVAY in the GA treatment space.

Toc32 Posted - 15 hours ago

$APLS Need to close above the 50DMA at 28.9 for any chance of a reversal. Scared money don't make money. Volume is still low which is fine because big money are accumulating . Scared money are here whining everyday and asking for a buy out which is not going happen at least until the kidney approval from the FDA.

mcdicedtea Posted - 16 hours ago

$APLS look at all those green candles. Stock dips only to be pushed higher. Smacks that someone has knowledge of something. What else can it be other than BO??? Time will tell but it drops and gets scooped up fast.

APman Posted - 16 hours ago

$APLS Why is there a 20c delta between bid and ask? People just buy and sell at market?

philosophernutz Posted - 1 day ago

$APLS So Astellas gets a CRL and the stock price doesn't flinch, the receptionist at $APLS calls out sick and the stock drops 30%, seriously WTF😒

Paul_Volcker Posted - 1 day ago

$APLS Some good analysis on X: https://x.com/BiotechSho99376/status/1859634768054452499

valueforme Posted - 1 day ago

$APLS very interesting to see this number of 30-32 price targets. Looks like the desire of investment banks to help shorts to cover and help their customers to build decent positions for 2025

Capitulation_0 Posted - 1 day ago

$APLS Competitor getting CRL. Came down a bunch. JP Morgan sees mid 40's as conservative price.

Sporked Posted - 1 day ago

$APLS can't find news, nice volume hit there with price moving

APman Posted - 1 day ago

$APLS Alright degens, is this it?

Georgeson Posted - 1 day ago

$APLS Interesting comments: https://x.com/BiotechSho99376/status/1859634768054452499

buylowandwait Posted - 1 day ago

$APLS Analyst targets all over the places, reflecting the GA dynamics. Recent CRL bodes well for APLS going forward. Might have to wait for a couple of more quarters.

APman Posted - 1 day ago

$APLS Sold 33%, lets see if it dips again tomorrow.

Toc32 Posted - 1 day ago

$APLS We need to see some good volume for any chance to retest $30.80. The buying volume has ben very low

Toc32 Posted - 1 day ago

$APLS A breakout of the 50% Fib retracement might bring more buyers.

Toc32 Posted - 1 day ago

$APLS The stock will move up when the whales are done accumulating , they know the Kidney approval is coming next year. Just buy on any pullback and book some profit if breakout point fails...